Advertisement

Topics

Pharmacopeia Drug Discovery Company Profile

22:07 EST 16th December 2018 | BioPortfolio

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase 1 clinical trials are underway. Other internal proprietary programs address primarily immunoregulation. Pharmacopeia's collaborative efforts have resulted in a portfolio that includes one partnered program currently in Phase 2 clinical trials targeting chronic obstructive pulmonary disease (COPD) and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. Four additional partnered compounds are in preclinical development. Pharmacopeia's current strategic partnerships are with Cephalon, GlaxoSmithKline, Organon and Wyeth.

Location

3000 Eastpark Blvd.
Cranbury
New Jersey
08512
United States of America

Contact

Phone: 609-452-3600
Fax: 609-452-3672
Email: webmaster@pharmacop.com


News Articles [1618 Associated News Articles listed on BioPortfolio]

Magnetic Resonance Mass Spectrometry for Fragment Based Drug Discovery

ArticleHigh throughput screening (HTS) has been the go-to technique for early-stage drug discovery for many years. Contributed Au

New USP Hazardous Drug Rules Coming Soon

The U.S. Pharmacopeia continues to revise its standards to protect workers exposed to hazardous drugs, including those involved in compounding medications.

C4X Discovery launches drug discovery partnership with LifeArc

C4X Discovery has formed a discovery partnership with British medical research charity LifeArc to collaborate on the development of small...Read More... The post C4X Discovery launches drug discovery ...

The Current issue of “The view from here” is concerned with Allosterism in Drug Discovery.

The topic of this month’s newsletter from Drug Discovery Today is “Allosterism in Drug Discovery”.

The Current issue of “The view from here” is concerned with nanoscience in drug discovery.

The topic of this month’s newsletter from Drug Discovery Today is “nanoscience in drug discovery”

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

Evotec Forms Drug Discovery Alliance With LEO On Dermatological Conditions

HAMBURG (dpa-AFX) - German drug discovery solutions company Evotec AG (EVTCY.PK, EVOTF.PK) announced a new integrated drug discovery alliance with LEO Pharma. The collaboration goal is to generate...

Researchers use AI to learn 'language' of drug discovery

Researchers from Israel are the latest to show that AI and deep learning could make the drug discovery process more efficient, by getting a computer to learn the “vocabulary” of drug discovery. I...

PubMed Articles [3149 Associated PubMed Articles listed on BioPortfolio]

Meeting the discovery challenge of drug-resistant infections: progress and focusing resources.

Following multiple warnings from governments and health organisations, there has been renewed investment, led by the public sector, in the discovery of novel antimicrobials to meet the challenge of ri...

Considerations for implementing an informatics system to support biologics drug discovery.

A comprehensive, well-functioning and scientifically aware informatics environment is of the utmost importance in supporting effective drug discovery programs. However, implementing such a system can,...

Challenges with risk mitigation in academic drug discovery: finding the best solution.

Renovation as innovation: is repurposing the future of drug discovery research?

Challenges with biomarkers in cancer drug discovery and development.

Clinical Trials [2510 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Using 'Guided-Discovery-Learning' to Optimize and Maximize Transfer of Surgical Simulation

The study is a randomized experimental study comparing two forms of learning; guided-discovery-learning and traditional instructional learning. Recruiting sixty-four participants, the inve...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Companies [2415 Associated Companies listed on BioPortfolio]

Pharmacopeia Incorporated

Pharmacopeia, Inc. is a leader in enabling technology and technology-based services that accelerate drug discovery and chemical development. Pharmacopeia's laboratory services segment - Pharmacopeia L...

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independen...

Pharmacopeia

Pharmacopeia is a biopharmaceutical company developing small molecule therapeutics to meet the needs of large patient populations suffering from significant unmet medical needs. With multiple internal...

Molecular Simulations Incorporated

Molecular Simulations Inc., a subsidiary of Pharmacopeia, Inc., is a leading provider of molecular modeling, simulation, and informatics software to the world’s foremost pharmaceutical, biotechnolog...

ZHONGBAO CHEMICALS CORP.,LTD

ZBChem is A member of Zhejiang ZhongBao I/E Corp.,Ltd Since 1963.ZBChem is the biggest China Excipients supplier and also supply many kinds of Cosmetic raw materials, Intermediates and API’s Guaran...

More Information about "Pharmacopeia Drug Discovery" on BioPortfolio

We have published hundreds of Pharmacopeia Drug Discovery news stories on BioPortfolio along with dozens of Pharmacopeia Drug Discovery Clinical Trials and PubMed Articles about Pharmacopeia Drug Discovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmacopeia Drug Discovery Companies in our database. You can also find out about relevant Pharmacopeia Drug Discovery Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...


Corporate Database Quicklinks



Searches Linking to this Company Record